TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31855906

Group type: EXPERIMENTAL
Intervention: PNs associated with HA (PNHA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) alone
Number of subjects: 100
Study: 28886992

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 98

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 98
Study: 26123410

Group type: EXPERIMENTAL
Intervention: Gadobutrol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Gadoterate meglumine
Number of subjects: 74
Study: 24375207

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 1049
Study: 22223569

Group type: EXPERIMENTAL
Intervention: Pasta with normal wheat bran (PA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bread with normal wheat bran (CB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bread with purple wheat bran (PBB)
Number of subjects: 10
Study: 19955827

Group type: EXPERIMENTAL
Intervention: Nebivolol added to antihypertensive treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 18818173

Group type: EXPERIMENTAL
Intervention: Intervention Group (n=100) - integrated intervention program including diabetes education, frequent blood glucose monitoring, nutritional counseling, meal plans with diabetes-specific nutritional meal replacement, and weekly progress updates
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intervention Group (n=100)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Reference Group (n=50) - received diabetes education including diet and physical activity instruction only
Number of subjects: 150
Study: 15801247

Group type: EXPERIMENTAL
Intervention: Diary cards
Number of subjects: 157

Group type: COMPARATOR
Intervention: Electronic monitoring
Number of subjects: 157
Study: 12444889

Group type: EXPERIMENTAL
Intervention: ATD combined with l‐thyroxine (l‐T(4))
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: ATD alone
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: TRAb positive after 12 Months of antithyroid therapy
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Large goiter
Number of subjects: 218
Study: 10551685

Group type: EXPERIMENTAL
Intervention: Thrombolytic administration
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 2195
Study: 7584765

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (20 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (40 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Codeine (30 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (10 mL sucrose)
Number of subjects: 20
Study: 1901280

Group type: EXPERIMENTAL
Intervention: hMG therapy (alone or in combination with clomiphene citrate or gonadotropin‐releasing hormone agonist analog)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No intervention (control group B)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: hMG therapy in oligomenorrhea and PCOD patients
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: hMG therapy in hypogonadotropic amenorrhea patients
Number of subjects: 140
Study: 6129142

Group type: EXPERIMENTAL
Intervention: Prenalterol (i.v. doses)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (i.v. doses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prenalterol (inhaled doses)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (inhaled doses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline (i.v. doses after prenalterol/saline)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prenalterol (i.v. and inhaled doses)
Number of subjects: 15
Study: 31594198

Group type: EXPERIMENTAL
Intervention: Suprahyoid muscle group (SMG) - NMES with electrodes placed between the jaw and hyoid bone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Infrahyoid muscle group (IMG) - NMES with electrodes placed below the hyoid for targeted infrahyoid muscles
Number of subjects: 38
Study: 30054843

Group type: EXPERIMENTAL
Intervention: Balanced Propofol Sedation (BPS)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Etomidate Sedation (BES)
Number of subjects: 186
Study: 28598231

Group type: EXPERIMENTAL
Intervention: 150 mg of ursolic acid once a day for 12 weeks
Number of subjects: 24
Study: 25579091

Group type: EXPERIMENTAL
Intervention: AK106‐001616 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AK106‐001616 400 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AK106‐001616 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: In vitro studies
Number of subjects: 0
Study: 23665051

Group type: EXPERIMENTAL
Intervention: Head Down Training Group (HTG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Upright Training Group (UTG)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Head Down Tilt Posture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Upright Posture
Number of subjects: 22
Study: 21504953

Group type: EXPERIMENTAL
Intervention: Thermal stimulation therapy (standard rehabilitation plus approximately 30-40 minutes of thermal stimulation daily for six weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation only)
Number of subjects: 36
Study: 19644227

Group type: EXPERIMENTAL
Intervention: Reboxetine (2-8 mg/d)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Methylphenidate (10-20 mg/d)
Number of subjects: 27
Study: 17853751

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion combined with nerve growth factor and rehabilitation training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rehabilitation training only (Control)
Number of subjects: 100
Study: 15201718

Group type: EXPERIMENTAL
Intervention: Spun-cast pHEMA lens
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cast-molded pHEMA lens
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: HEMA/GMA lens
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Other pHEMA lenses (lathing and cast molding)
Number of subjects: 34
Study: 11685302

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 26
Study: 9135360

Group type: EXPERIMENTAL
Intervention: midazolam 0.025 mg kg‐1 i.m.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: midazolam 0.075 mg kg‐1 i.m.
Number of subjects: 6

Group type: COMPARATOR
Intervention: control (no midazolam administration)
Number of subjects: 6
Study: 8361252

Group type: EXPERIMENTAL
Intervention: VA‐ADHC services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contract ADHC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VA‐ADHC
Number of subjects: 0
Study: 3706112

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30458778

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs)
Number of subjects: 6111

Group type: EXPERIMENTAL
Intervention: Medical Assistants (MAs)
Number of subjects: 6111

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6111
Study: 27600828

Group type: EXPERIMENTAL
Intervention: Facilitated by a fourth-year student who is a Gold Humanism Honor Society member (GHHS)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Facilitated by a volunteer non-GHHS student
Number of subjects: 186

Group type: COMPARATOR
Intervention: Non-facilitated groups
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study: 24239324

Group type: EXPERIMENTAL
Intervention: 0.75 mg/kg primaquine
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg primaquine
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg primaquine
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 23107470

Group type: EXPERIMENTAL
Intervention: Conventional Western medicine and Bu‐Fei Jian‐Pi granules, Bu‐Fei Yi‐Shen granules, and Yi‐Qi Zi‐Shen granules
Number of subjects: 352
Study: 20660231

Group type: EXPERIMENTAL
Intervention: Dynamic external fixation
Number of subjects: 70
Study: 18400400

Group type: EXPERIMENTAL
Intervention: Pregabalin (optimal fixed dosages of 300, 450, 600 mg/d)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1051
Study: 16085585

Group type: EXPERIMENTAL
Intervention: MDCT angiography
Number of subjects: 25

Group type: COMPARATOR
Intervention: MPI
Number of subjects: 25
Study: 12583552

Group type: EXPERIMENTAL
Intervention: 5-day treatment course with oral moxifloxacin (MXF)
Number of subjects: 476

Group type: COMPARATOR
Intervention: 7-day course with i.m. ceftriaxone (CRO)
Number of subjects: 476
Study: 12197575

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Formoterol 24 microg
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study: 9640223

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) at a dose of 150 U/kg/dose subcutaneously three times/week for a minimum of 12 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 8126238

Group type: EXPERIMENTAL
Intervention: Plax
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2530318

Group type: EXPERIMENTAL
Intervention: Circadian patterned variable rate infusion of floxuridine (FUDR)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Constant rate infusion of floxuridine (FUDR)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Time-modified FUDR infusion
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: FUDR infusion
Number of subjects: 54
Study: 1067726

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (n = 36)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sucrose chewing gum (n = 32)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no chewing gum, n = 28)
Number of subjects: 96
Study: 31242884

Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 0
Study: 28343659

Group type: EXPERIMENTAL
Intervention: 30 mg zinc oxide (n=144)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: 30 mg ferrous fumarate (n=148)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Iron and zinc together (n=148)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo (n=151)
Number of subjects: 602
Study: 26148003

Group type: EXPERIMENTAL
Intervention: modified Fitness Counts (mFC)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise Training (PRET)
Number of subjects: 51
Study: 23672385

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Detraining
Number of subjects: 21
Study: 21689865

Group type: EXPERIMENTAL
Intervention: Aerosolized buccal midazolam
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Aerosolized intranasal midazolam
Number of subjects: 169

Group type: COMPARATOR
Intervention: Oral midazolam
Number of subjects: 169
Study: 20120262

Group type: EXPERIMENTAL
Intervention: Articulated motion of structurally similar objects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scrambled controls
Number of subjects: 0
Study: 16483431

Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration of metronidazole (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Irrigation with saline (group A)
Number of subjects: 60
Study: 12603860

Group type: EXPERIMENTAL
Intervention: Topical glucocorticoid (clobetasol), applied for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical applications of an equimolar distribution of free fatty acids, cholesterol, and ceramides
Number of subjects: 0
Study: 10934653

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 160
Study: 9007943

Group type: EXPERIMENTAL
Intervention: Evidence-based care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research studies evaluated using rules of evidence
Number of subjects: 0
Study: 8165610

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (adapted doses, continuous intravenous)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Enoxaparin (1 mg/kg every twelve hours, subcutaneously)
Number of subjects: 91
Study: 30807970

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: miRNA-107
Number of subjects: 0
Study: 26263787

Group type: EXPERIMENTAL
Intervention: O. hupensis snail crushers
Number of subjects: 109

Group type: COMPARATOR
Intervention: Crushing method
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Crushing and shedding method with O. hupensis snail crushers
Number of subjects: 109
Study: 23464876

Group type: EXPERIMENTAL
Intervention: Achromatic (black/white) patterns at 3 and 12 cpd
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Tritan (black/purple, black/yellow) patterns
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Protan/deutan (black/red, black/green) patterns
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 12 cpd gratings
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 3 cpd gratings
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Contrast sensitivity measures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Visual migraine/headache triggers
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Visual discomfort scale
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Achromatic visual discomfort measures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Chromatic discomfort measures
Number of subjects: 42
Study: 20804506

Group type: EXPERIMENTAL
Intervention: Antioxidants (AOx) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunscreen (SS) alone (SPF 25)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AOx plus SS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunscreen (SS) plus AOx only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ssUVR only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated (neither ssUVR nor product)
Number of subjects: 0
Study: 19255393

Group type: EXPERIMENTAL
Intervention: Sickle cell disease with osteomyelitis (case patients)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Duration of fever
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Duration of pain
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Swelling of the affected limb
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: More than 1 painful site
Number of subjects: 124
Study: 17061441

Group type: EXPERIMENTAL
Intervention: High vegetables intake (last quintile)
Number of subjects: 6427

Group type: EXPERIMENTAL
Intervention: High fruits intake
Number of subjects: 6427

Group type: COMPARATOR
Intervention: Control group (lower vegetables intake, first quintile)
Number of subjects: 6427
Study: 15019661

Group type: EXPERIMENTAL
Intervention: ELP bioprosthesis
Number of subjects: 81

Group type: COMPARATOR
Intervention: MM bioprosthesis
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Comparison of both valves
Number of subjects: 81
Study: 11697840

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel 36 mg/m2 i.v. administered weekly for six consecutive weeks followed by two weeks without treatment
Number of subjects: 25
Study: 9783561

Group type: EXPERIMENTAL
Intervention: Alcoholic patients
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Alcohol consumption during follow-up
Number of subjects: 44
Study: 8151485

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine 5% cream (EMLA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 3143625

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition and nil by mouth (n = 17)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Defined formula diet administered through a nasogastric tube (n = 19)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Partial parenteral nutrition and oral food (n = 15)
Number of subjects: 51
Study: 30457967

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 0
Study: 28892156

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) in beverage at 0, 8, 12, and 16 g
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) in bar at 0 and 12 g
Number of subjects: 53
Study: 25748110

Group type: EXPERIMENTAL
Intervention: Health care improvement intervention at health centres
Number of subjects: 0
Study: 23017510

Group type: EXPERIMENTAL
Intervention: Saw palmetto treatment
Number of subjects: 357
Study: 20642342

Group type: EXPERIMENTAL
Intervention: Center based rehabilitation
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Home based rehabilitation
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Mix of center based and home based rehabilitation
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Center based rehabilitation with home based non interventional supplementary visits
Number of subjects: 436
Study: 18803093

Group type: EXPERIMENTAL
Intervention: Transfer Technique (TT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Transfer Technique and Physical Training (TTPT)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control (usual routine)
Number of subjects: 181
Study: 16586079

Group type: EXPERIMENTAL
Intervention: 99mTc-tetrofosmin SPECT
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 18F-fluorodeoxyglucose (FDG) PET
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Preserved flow with decreased glucose metabolism
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Decreased flow with preserved glucose metabolism
Number of subjects: 28
Study: 12740741

Group type: EXPERIMENTAL
Intervention: GHRH alone (100 microg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Exercise alone (EX)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GHRH + EX (100 microg GHRH with exercise)
Number of subjects: 8
Study: 10970684

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with SRL172 (Mycobacterium vaccae)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 28
Study: 8792771

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Oral contraceptive use
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Age and cholesterol levels
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Age and menopausal status
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: FVIIa levels
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Age, sex, and menopause-related changes in FVIIc
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: FVIIa
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: FVIIc and FVIIa levels
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Mean values of FVIIc and FVIIa
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 684
Study: 1467127

Group type: EXPERIMENTAL
Intervention: Very low protein diet (0.4 g of protein/kg b.w./day) supplemented with essential amino acids
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional low protein diet (0.6 g of protein/kg b.w./day)
Number of subjects: 21
Study: 6419809

Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 30556832

Group type: COMPARATOR
Intervention: NRT (Nicotine Replacement Therapy)
Number of subjects: 624

Group type: COMPARATOR
Intervention: NRT plus text messaging
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: NRT plus text messaging plus proactive counseling via mobile phone
Number of subjects: 624
Study: 28097646

Group type: EXPERIMENTAL
Intervention: Visuospatial intervention programme (10-week, 20 hours of activities)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard mathematics instruction (control group)
Number of subjects: 186
Study: 27416906

Group type: EXPERIMENTAL
Intervention: Day-Camp Intervention Arm (DCIA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard Intervention Arm (SIA)
Number of subjects: 115
Study: 24273179

Group type: EXPERIMENTAL
Intervention: Cervarix
Number of subjects: 92

Group type: COMPARATOR
Intervention: Gardasil
Number of subjects: 92
Study: 22896733

Group type: EXPERIMENTAL
Intervention: Choice White Grease (CWG) diet
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Animal-Vegetable blend (A-V) diet
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 391
Study: 19254671

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (45 mg, 3 times/day, for 24 hours)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 17202549

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 15037335

Group type: EXPERIMENTAL
Intervention: PANSS cognitive factor
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Five PANSS items (P6, N5, N6, G2, G10)
Number of subjects: 167
Study: 11750185

Group type: EXPERIMENTAL
Intervention: 20 mg of d-amphetamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10